Introduction {#s1}
============

Malaria, caused by *Plasmodium* parasites, continues to pose serious health threats to developing areas of the world, especially sub-Saharan Africa and Southeast Asia ([@bib88]). Antibody production is critical for clearance of both human- and murine-tropic strains of the blood-stage parasite ([@bib11]; [@bib14]; [@bib32]; [@bib53]; [@bib67]). CD4^+^ T cells are an important component of this response based on their role in eliciting T cell--dependent antibodies ([@bib43]; [@bib50]). Several studies have demonstrated that the acute response to a blood-stage *Plasmodium* infection in both humans and mice is dominated by CD4^+^ T follicular helper (Tfh) cells that provide help to B cells ([@bib27]; [@bib58]; [@bib63]). However, it remains unknown how an endogenous antigen-specific Tfh population induced by *Plasmodium* infection forms or differentiates into a memory pool. Unlike in humans ([@bib76]), acute *Plasmodium* infection in mice results in sterile immunity to reinfection initiated soon after the primary infection ([@bib54]). However, this period of sterilizing immunity to blood-stage parasites in mice is not lifelong ([@bib22]; [@bib54]); this raises questions about the formation and maintenance of memory cells in this model, which could illuminate failures of the human memory response to malaria. We developed a system to interrogate the development of the CD4^+^ memory T cell response to *Plasmodium* infection in mice with the hopes of gaining insights to enhance human immunity by vaccination.

Analysis of the expression of cell surface markers and fate-determining transcription factors by CD4^+^ T cells during *Plasmodium* infection demonstrates that the CD4^+^ T cell response is skewed to the Tfh phenotype (broadly defined as CXCR5^+^ BCL6^+^) as described in both humans and mice ([@bib27]; [@bib58]; [@bib63]). Tfh cells interact with activated B cells at the T--B border between B cell follicles and T cell zones in lymphoid tissues and can develop into germinal center (GC) Tfh cells (CXCR5^+^ PD-1^+^; [@bib31]; [@bib66]). Endogenous, epitope-specific polyclonal cells responding to either bacterial or viral infections tend to generate similar proportions of Tfh cells and non-Tfh T effector (Teff) cells at the population level due to heterogeneity within the naive CD4^+^ T cell repertoire ([@bib77]). This division of labor is evident within the first 5--10 d after infection and is thought to be driven initially by dendritic cell (DC) priming, followed by interactions with B cells ([@bib28]; [@bib62]). Studies in bacterial and viral infections have also demonstrated that the Tfh population can then seed a CD4^+^ central memory T (T~CM~) cell population (CCR7^+^ CXCR5^+^), which can reactivate in secondary challenges to express cytokines and help B cells ([@bib16]; [@bib20]; [@bib62]). It is unclear why *Plasmodium* infection generates a dominant (∼90%) Tfh response and how this skewing relates to memory formation of the antigen-specific cells ([@bib22]). To this end, we studied the development of *Plasmodium*-specific CD4^+^ T cells and the factors influencing their differentiation.

We used a transgenic *Plasmodium yoelii* parasite that expresses a peptide from the lymphocytic choriomeningitis virus (LCMV) to compare GP66-specific (GP66^+^) CD4^+^ T cells in the context of *Plasmodium* or LCMV infection. This allowed us to compare the kinetics and differentiation of a single epitope-specific population with the same TCR repertoire responding to different infections. Recent work argues that within a polyclonal CD4^+^ T cell population, TCR affinity and signal strength strongly dictate the differentiation of Tfh cells ([@bib39]; [@bib40]; [@bib42]; [@bib77]). Our approach interrogated the impact of distinct priming environments on directing the differentiation of the same epitope-specific population within different contexts. We found that GP66^+^ CD4^+^ T cells responding to *Plasmodium* infection exhibited reduced proliferative capacity compared with GP66^+^ cells responding to viral infection. Furthermore, we confirmed not only that a significant Tfh population arose at the peak of the response to *Plasmodium* ([@bib63]) but also that \>80% of the CD4^+^ T cells exhibited a Tfh phenotype as early as 4 d after infection, suggesting an altered priming environment in response to *Plasmodium*. Further investigation revealed that while DCs were not required for the priming or differentiation of the CD4^+^ T cells during *Plasmodium* infection, B cells were both necessary and sufficient. We showed that both antigen presentation by B cells and T cell interpretation of costimulatory signals independently contributed to the expansion and differentiation of the GP66^+^ Tfh response, respectively. These studies challenge the paradigm that CD4^+^ T cells must first be primed by DCs before interacting with a B cell and suggest that in addition to TCR affinity and antigen load, the APC that primes the CD4^+^ T cell can influence its differentiation.

Results and discussion {#s2}
======================

Epitope-specific CD4^+^ T cells exhibit limited expansion in response to *Plasmodium* infection {#s3}
-----------------------------------------------------------------------------------------------

To study an antigen-specific CD4^+^ T cell response to *P. yoelii* infection, we used a transgenic parasite expressing a well-characterized CD4^+^ T cell epitope derived from the GP of LCMV, GP~66--80~ (*Py-GP66*; [@bib17]; [@bib27]; [@bib91]). This allowed us to use the previously generated GP~66--77~:I-Ab tetramer and magnetic bead enrichment to examine rare, antigen-specific cells responding early in infection ([@bib52]). To gain an understanding of the kinetics of the response, we first compared GP66^+^ cells in LCMV and *Py-GP66* infections at various time points ([Fig. 1, A and B](#fig1){ref-type="fig"}). Comparable numbers of CD44^+^ GP66^+^ cells emerged from the naive precursor population of ∼100 cells as early as 4 d after infection with either *Py-GP66* or LCMV. However, whereas this reached a peak of ∼4,000 cells at 12 d after infection with *Py-GP66,* it expanded to ∼80,000 cells 12 d after LCMV infection, consistent with previous reports ([@bib46]; [@bib55]; [@bib86]; [Fig. 1 B](#fig1){ref-type="fig"}). Furthermore, in LCMV, the numbers of GP66^+^ cells contracted with viral clearance and then stabilized to maintain a population of long-lived memory cells, as previously described ([@bib13]; [@bib33]; [@bib48]).

![**Epitope-specific CD4^+^ T cells exhibit limited expansion in response to *Plasmodium* infection. (A)** At acute and late time points after infection with LCMV or *Py-GP66*, the activation and expansion of GP66^+^ CD4^+^ T cells from secondary lymphoid organs were assessed by flow cytometry. Plots are gated on dump^−^ CD3^+^ CD8^−^ CD4^+^ cells. **(B)** Graph shows the number of GP66^+^ cells from both infections over time. The fold change in the cell number from *Py-GP66* infection is indicated above the LCMV curve. Data are pooled from four to eight mice from each cohort at each time point from at least two independent experiments. A nonlinear regression from the peak at day 12 to day 150 was performed for each infection and is indicated by the dashed lines. The slope of the *Py-GP66* line is −7.001 (−17.75 to 3.747), and the slope of the LCMV line is 31.15 (−170.7 to 233). The regressions were analyzed by *F* test. **(C)** CFSE-labeled GP66-specific transgenic CD4^+^ T cells (SMARTA) were transferred to WT mice and infected with LCMV or *Py-GP66*. Numbers of cell divisions are indicated on gates. Both histograms are gated on SMARTA^+^ CD44^+^ GP66^+^ T cells. **(D)** Responder frequency and proliferative capacity of SMARTA^+^ CD44^+^ GP66^+^ cells were calculated as previously described ([@bib25]). Data are pooled from 7--10 mice per cohort from two independent experiments and were analyzed by unpaired *t* test. For B and D, data are shown as means ± SEM. \*, P \< 0.05; \*\*\*\*, P \< 0.0001. dpi, days post-infection; ns, not significant.](JEM_20190849_Fig1){#fig1}

During *Plasmodium* infection, however, the number of CD44^+^ GP66^+^ cells continued to decline ([Fig. 1 B](#fig1){ref-type="fig"}). We analyzed the contraction of GP66^+^ cells from the peak at 12 d after infection to 150 d after infection by nonlinear regression (dashed lines). The slopes of the lines (31.15 for LCMV and −7.001 for *Py-GP66*) demonstrate that the contraction/memory phases have statistically different kinetics. As these differences begin early in the induction of the adaptive immune responses to these infections, we sought to examine how early events during the initiation of the GP66^+^ response may differentially impact the resulting expansion and maintenance of the cells.

Differences in the number of GP66^+^ cells in the two infections could arise due to multiple factors that affect how antigen is perceived at these early time points. Changes in antigen load can alter clonal expansion and the degree of T cell contraction ([@bib61]); differences in TCR signal strength can alter the transcriptional events downstream of TCR stimulation ([@bib37]); and alterations in costimulatory signals can sustain the proliferative burst ([@bib35]; [@bib49]). T cell responsiveness during priming can be compared by measuring the responder frequency and proliferative capacity, which are associated with the perception of antigen and the maintenance of the proliferative burst ([@bib25]). To address these possibilities, we adoptively transferred CFSE-labeled TCR transgenic CD4^+^ T cells specific for the GP66 epitope (SMARTA; [@bib60]) into congenically marked WT recipients infected with LCMV or *Py-GP66* 1 d after transfer. We found that in both infections, GP66^+^ SMARTA cells undergo at least seven rounds of proliferation based on the dilution of CFSE ([Fig. 1 C](#fig1){ref-type="fig"}). We calculated both the responder frequency (the fraction of input SMARTA cells that proliferated at least once) and the proliferative capacity (the number of daughter cells generated per input SMARTA precursor cell; [@bib25]). There was no difference in the responder frequency between the LCMV and *Py-GP66* infections, indicating comparable access to antigen in both infections. However, there was a marked decrease in the proliferative capacity of the GP66^+^ SMARTA cells during *Plasmodium* infection, suggesting differential interpretation of costimulation ([Fig. 1 D](#fig1){ref-type="fig"}). These data demonstrate that the conditions required to sustain cell division, which can also influence cell fate, may be altered at an early stage in response to a *Plasmodium* infection.

Epitope-specific CD4^+^ T cells express CXCR5 at both acute and memory time points after infection {#s4}
--------------------------------------------------------------------------------------------------

To gain a greater understanding of how the differentiation of these two epitope-specific populations occurs, we also examined the phenotype of the GP66^+^ CD4^+^ T cells in the context of the two infections. Current models suggest that a two-step process initiated by priming via a DC followed by subsequent interactions with B cells results in Tfh cell differentiation ([@bib45]; [@bib65]). The initial interactions between DCs and CD4^+^ T cells are thought to drive an early bifurcation of activated CD4^+^ T cells into a Tfh or Teff pathway based on their ability to express CXCR5 or the IL-2Rα chain, respectively ([@bib8]; [@bib62]; [@bib77]). Tfh cells that upregulate BCL6 and CXCR5 migrate to the T--B border of secondary lymphoid organs where the Tfh phenotype is maintained by interactions with B cells ([@bib6]; [@bib9]; [@bib15]; [@bib23]; [@bib31]; [@bib38]; [@bib56]; [@bib57]; [@bib65]; [@bib66]; [@bib70]; [@bib83]).

We therefore first determined the kinetics of activated (CD44^+^) GP66^+^ CD4^+^ T cell differentiation in the two infections to understand how early the Tfh phenotype emerges. In uninfected animals, GP66^+^ cells did not express CXCR5, as expected ([Fig. 2 A](#fig2){ref-type="fig"}; [@bib77]). At 4 d after infection, we could consistently find an expanded population of GP66^+^ cells in both infections. In LCMV-infected mice, only a small proportion of GP66^+^ cells expressed CXCR5 at this time point; yet the vast majority (∼80%) of GP66^+^ cells responding to *Plasmodium* already expressed CXCR5 ([Fig. 2 A](#fig2){ref-type="fig"}). The global CD44^+^ CD4^+^ T cell population exhibits similarly enhanced Tfh skewing in response to *Plasmodium* infection compared with LCMV infection (Fig. S1, A and B). Approximately half of the cells responding to LCMV exhibited a Tfh phenotype by day 8, as previously described ([@bib77]; [@bib89]), though the frequency of CXCR5^+^ GP66^+^ cells continued to increase until day 20. In contrast, GP66^+^ cells induced by *Plasmodium* infection maintained a predominant CXCR5^+^ Tfh phenotype at all time points observed ([Fig. 2, A and B](#fig2){ref-type="fig"}). We confirmed that the CXCR5^+^ cells formed in *Plasmodium* infection were bona fide Th1 Tfh cells through analysis of the fate-determining transcription factors for this subset, T-bet and BCL6 ([@bib6]). While it was difficult to perform these studies on the low numbers of GP66^+^ cells at day 4, by day 8 after infection with *Plasmodium*, the majority of GP66^+^ cells expressed high levels of BCL6 and lower levels of T-bet, consistent with a Th1 Tfh phenotype (Fig. S1, C and D; [@bib58]). Together, these data demonstrate that the same epitope-specific population can adopt different frequencies of Tfh versus Teff phenotypes with different kinetics in response to different infections. These data further suggest that some aspect of *Plasmodium* infection commits the GP66^+^ cells to a stable Tfh phenotype very early in infection.

![**Epitope-specific CD4^+^ T cells express CXCR5 at both acute and memory time points after infection. (A)** Representative flow plots of antigen-specific CD4^+^ T cells isolated from secondary lymphoid organs at naive or acute time points after LCMV or *Py-GP66* infection. Plots are gated on dump^−^ CD3^+^ CD8^−^ CD4^+^ CD44^+^ GP66^+^ cells. **(B)** Summary data of the percentage of CXCR5^+^ GP66^+^ cells shown in A (denoted by red gates). This quantification method for total CXCR5^+^ cells, including Tfh and GC Tfh at acute time points and CXCR5^+^ T~CM~ at later time points, is used throughout the paper. Data are pooled from four to eight mice per time point from at least two independent experiments and were analyzed by two-way ANOVA. **(C)** Representative flow plots of GP66-specific CD4^+^ T cells at memory time points after LCMV (L) or *Py-GP66* (P) infection. Frequencies of CXCR5^+^ cells are indicated in the plots. **(D)** Summary data of the percentage of CXCR5^+^ GP66^+^ cells shown in C. Data are pooled from four to six mice per time point from at least two independent experiments and were analyzed by two-way ANOVA. **(E)** Representative flow plots from GP66^+^ CD4^+^ T cells at memory time points after *Py-GP66*. CCR7^+^ T~CM~ cells and CCR7^−^ T~EM~ populations are shown. GC Tfh cells are included in the CCR7^−^ CXCR5^+^ population ([@bib31]). **(F)** Summary data of the percentage of the T~CM~ and the T~EM~ populations from E. Data are pooled from 3 to 10 mice per time point from at least two independent experiments and were analyzed by unpaired *t* test. For B, D, and F, data are shown as means ± SEM. \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001; \*\*\*\*, P \< 0.0001. dpi, days post-infection.](JEM_20190849_Fig2){#fig2}

We next assessed the stability of this early Tfh population by analyzing the GP66^+^ cells at later time points. We hypothesized that the early Tfh cell differentiation would later result in a central memory population, as previously described in Th1 cell--skewed responses to bacterial and viral infections ([@bib16]; [@bib62]). 50 d after either infection, the majority of GP66^+^ cells maintained a CXCR5^+^ Tfh phenotype; however, at later time points, the frequency of CXCR5^+^ cells decreased in the LCMV-infected mice, while *Plasmodium*-infected mice maintained ∼80% CXCR5^+^ cells ([Fig. 2, C and D](#fig2){ref-type="fig"}). Of note, the level of CXCR5 expression, as determined by mean fluorescence intensity, on the GP66^+^ cells after LCMV infection was consistently higher than after *Plasmodium* infection at all the time points tested, despite the frequency of total CXCR5^+^ cells being generally higher in response to *Plasmodium* infection than to LCMV infection ([Fig. 2, C and D](#fig2){ref-type="fig"}).

To determine the types of memory cells that form in response to *Plasmodium* infection, we also assessed markers that distinguish central and effector memory cells (CCR7 and CD62L; [@bib71]). Gates were drawn using the expression of CCR7 and CXCR5 on global CD4^+^ T cells and CD44^+^ CD4^+^ T cells (Fig. S1 E). We demonstrated that GP66^+^ memory T cells following *Plasmodium* infection largely adopted a T~CM~ (CCR7^+^ CXCR5^+^) phenotype ([Fig. 2 E](#fig2){ref-type="fig"}). This skewing in the memory pool was observed at all time points examined up to 260 d after infection ([Fig. 2 F](#fig2){ref-type="fig"}). These data therefore demonstrate that the early differentiation of CXCR5^+^ Tfh cells observed was maintained as a CXCR5^+^ T~CM~ cell population, suggesting that this is a stable phenotype, imprinted early in the response to *Plasmodium* infection.

The Tfh-skewed epitope-specific CD4^+^ T cell response is B cell dependent {#s5}
--------------------------------------------------------------------------

We next focused on understanding the factors that could be driving this stable CXCR5^+^ Tfh/T~CM~--skewed phenotype. As described above, Tfh cell differentiation is thought to be a two-step process depending on early priming by DCs and later maintenance of the Tfh phenotype by B cells. We therefore hypothesized that CD4^+^ T cells activated in the absence of B cells would show no phenotypic differences at day 4 but would fail to maintain the Tfh phenotype later. We tested this hypothesis by infecting WT and μMT mice, which lack mature B cells, with *Py-GP66* and examined the phenotype of GP66^+^ cells in each group at various time points. Interestingly, we observed that even as early as 4 d after infection there was a significant loss of CXCR5 expression by GP66^+^ cells in the μMT mice ([Fig. 3 A](#fig3){ref-type="fig"}). Later, a small population of Tfh cells emerged, which was consistently half as frequent in the μMT mice as in the WT mice ([Fig. 3, A and B](#fig3){ref-type="fig"}). Although the exact kinetics of cell expansion in this experiment differed from the more extensive analyses shown in [Fig. 1 B](#fig1){ref-type="fig"} due to the biological variation associated with infection,the number of GP66^+^ cells was consistently lower in μMT mice than in WT mice during the acute response to *Plasmodium* infection ([Fig. 3 B](#fig3){ref-type="fig"}). These data suggest that B cells play a crucial role in the CD4^+^ T cell response to *Plasmodium* infection before day 4. We were unable to study these cells beyond day 15 due to fatality in the μMT mice resulting from a high parasite burden (Fig. S2 A; [@bib68]; [@bib84]). Since μMT animals are known to have aberrant lymphoid organization ([@bib10]), we also depleted B cells in WT mice with anti-CD20 antibody administered on the day of and 3 d after infection with *Py-GP66*. We achieved 81% reduction of B cells in the spleen with this treatment compared with the isotype-treated control (Fig. S2 B). At 4 d after infection, we observed that transient depletion of B cells decreased the Tfh population by ∼20% compared with the isotype-treated control ([Fig. 3, C and D](#fig3){ref-type="fig"}). The B cell depletion resulted in a decreased number of GP66^+^ cells, though this was not significant. ([Fig. 3 D](#fig3){ref-type="fig"}). These alterations in differentiation occurred without appreciable increases in the parasite burden compared with that of WT controls, suggesting no critical role for antibody production at early time points (Fig. S2, A and C). These data support our hypothesis that B cells are critical for providing very early signals in response to *Plasmodium* infection, and even partial depletion of B cells can affect the early differentiation of a predominant *Plasmodium*-specific Tfh response.

![**The Tfh-skewed epitope-specific CD4^+^ T cell response is B cell dependent. (A)** Representative flow plots demonstrating CXCR5 expression on antigen-specific CD4^+^ T cells at acute time points after *Py-GP66* infection in WT and μMT mice. Plots are gated on dump^−^ CD3^+^ CD8^−^ CD4^+^ CD44^+^ GP66^+^ cells. **(B)** Summary data of the percentage of CXCR5^+^ GP66^+^ cells and number of GP66^+^ cells from A. Data are pooled from three to six mice per cohort from at least two independent experiments and were analyzed by unpaired *t* test. **(C)** WT mice were treated with anti-CD20 antibody or isotype control immediately before infection and on day 3 after infection. Representative flow plots of GP66^+^ cells from the secondary lymphoid organs of mice infected 4 d prior with *Py-GP66*. **(D)** Summary data of the percentage of CXCR5^+^ GP66^+^ cells and number of GP66^+^ cells from C. Data are pooled from six mice per cohort from two independent experiments and were analyzed by unpaired *t* test. For B and D, data are shown as means ± SEM. \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001. Ab, antibody; dpi, days post-infection; ns, not significant.](JEM_20190849_Fig3){#fig3}

B cells are necessary and sufficient to prime the GP66^+^ CD4^+^ T cell response, while DCs are dispensable {#s6}
-----------------------------------------------------------------------------------------------------------

CD4^+^ T cells interpret multiple signals from professional APCs during priming, including presentation of antigen on peptide:MHC complexes and ligand/receptor pair interactions, referred to as costimulation. Many reports indicate that DCs serve as the initial APC for Tfh cell differentiation in various infections ([@bib4]; [@bib7]; [@bib15]; [@bib36]). Previous studies identified conventional DCs (cDCs) as the critical APC during *Plasmodium* infection ([@bib21]; [@bib78]; [@bib82]). However, these studies used CD11c as the cDC marker, which is also upregulated by activated B cells, CD4^+^ T cells, CD8^+^ T cells, natural killer (NK) cells, and NK T cells ([@bib69]; [@bib72]; [@bib75]; [@bib85]). In other studies, DCs have been shown to have dysfunctional responses during blood-stage *Plasmodium*, including a reduced capacity for antigen uptake and antigen presentation ([@bib24]; [@bib44]; [@bib64]; [@bib79]; [@bib87]; [@bib90]).

We therefore tested whether cDCs were involved in CD4^+^ T cell priming during *Plasmodium* infection using a more specific deletion of cDCs. We used the Zbtb46-DTR (zDC-DTR) mouse model, in which administration of diphtheria toxin specifically depletes the cDC compartment without affecting plasmacytoid DCs, macrophages, monocytes, or NK cells ([@bib51]). We achieved a 77% depletion of the cDC compartment in these mice 2 d after treatment (Fig. S3 A) and found that in the absence of cDCs, GP66^+^ cells maintain a prominent Tfh skewing at day 4 after infection ([Fig. 4 A](#fig4){ref-type="fig"}). Furthermore, we observed no significant changes in the frequency of CXCR5^+^ cells or the number of GP66^+^ cells ([Fig. 4 B](#fig4){ref-type="fig"}). Together, these data demonstrate that cDCs are not necessary to activate *Plasmodium*-specific CD4^+^ T cells or to promote Tfh cell differentiation in the context of this infection. Our approach allows for the dissection of the specific contribution of the cDCs and demonstrates that they are dispensable for activation of *Plasmodium*-specific CD4^+^ T cells.

![**B cells are necessary and sufficient to prime the GP66^+^ CD4^+^ T cell response, whereas DCs are dispensable. (A)** Representative flow plots of GP66^+^ cells from 4 d after infection with *Py-GP66* in WT and zDC-DTR mice. Both cohorts were treated with diphtheria toxin (DTx) at 1 and 2 d after infection. **(B)** Summary data of the percentage of CXCR5^+^ GP66^+^ cells and number of GP66^+^ cells in A. Data are pooled from five mice per cohort and are representative of two independent experiments. Data were analyzed by unpaired *t* test. **(C)** Representative flow plots showing transferred SMARTA^+^ GP66^+^ cells 4 d after infection with LCMV or *Py-GP66* in WT and B-MHC II mice. Plots are gated on dump^−^ CD3^+^ CD8^−^ CD4^+^ CD44^+^ GP66^+^ cells. **(D)** Summary data of the percentage of CXCR5^+^ SMARTA^+^ GP66^+^ cells and number of SMARTA^+^ GP66^+^ cells shown in C. Data are pooled from 8--15 mice per cohort and are representative of three independent experiments. Data were analyzed by two-way ANOVA. **(E)** Representative flow plots of endogenous GP66^+^ CD4^+^ T cells from MB1-Cre^−^ MHC^fl/fl^ or MB1-Cre^+^ MHC^fl/fl^ mice infected with *Py-GP66* 4 d prior. **(F)** Summary data of the percentage of CXCR5^+^ GP66^+^ cells and number of GP66^+^ cells shown in E. Data are representative of five mice per cohort from two independent experiments and were analyzed by unpaired *t* test. **(G)** MB1-Cre^+^ MHC^fl/fl^ mice were treated with a-CD40L + a-ICOSL antibodies or isotype controls daily 0--3 d after infection. Representative flow plots from GP66^+^ cells 4 d after infection with *Py-GP66*. **(H)** Summary data of the percentage of CXCR5^+^ GP66^+^ cells and number of GP66^+^ cells from G. Data are pooled from five or six mice per cohort and are representative of two independent experiments. Data were analyzed by unpaired *t* test. For B, D, F, and H, data are shown as means ± SEM. \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*\*, P \< 0.0001. ns, not significant.](JEM_20190849_Fig4){#fig4}

We next examined whether, alternatively, B cells could be priming CD4^+^ T cells in response to *Plasmodium* infection. Following activation, B cells upregulate MHC II and costimulatory molecules, demonstrating their capacity to prime naive CD4^+^ T cells ([@bib4]; [@bib12]; [@bib30]; [@bib34]; [@bib41]). Additionally, B cell priming has been demonstrated in vivo using mice that only express MHC II (I-Ab) on CD19^+^ B cells (B-MHC II). In B-MHC II mice, antigen presentation by B cells was shown to be sufficient to drive the expansion and formation of antigen-specific Tfh cells in response to immunization ([@bib12]) and during viral infection ([@bib4]; [@bib19]; [@bib34]). We used these mice to determine whether a similar phenomenon could occur in response to *Plasmodium* infection. Since B-MHC II mice do not develop a normal CD4^+^ T cell compartment due to the lack of positive selection ([@bib4]), it is necessary to adoptively transfer CD4^+^ T cells and examine these. We transferred TCR transgenic SMARTA CD4^+^ T cells specific for the GP66 epitope into WT or B-MHC II mice 1 d before infection with LCMV or *Py-GP66* and analyzed the differentiation of these cells 4 d after infection. As expected, the absence of DC-derived priming hampered the expansion of GP66^+^ SMARTA cells responding to LCMV infection but did not impact expansion during *Plasmodium* infection. We observed a small decrease in the expression of CXCR5 at 4 d after infection when cells were responding to LCMV infection. Remarkably, in response to *Plasmodium* infection, the GP66^+^ SMARTA cells in B-MHC II mice developed a prominent Tfh skewing that closely resembled their phenotype in WT controls ([Fig. 4, C and D](#fig4){ref-type="fig"}).

To perform the converse experiment, we generated MB1-Cre^+^ MHC II^fl/fl^ mice to delete the β chain of the I-Ab MHC II molecule from B cells, thus preventing B cells from presenting antigen. 4 d after infection with *Py-GP66*, there was a 10% decrease in Tfh frequency and a sevenfold reduction in the total number of GP66^+^ cells generated in mice lacking MHC class II on B cells ([Fig. 4, E and F](#fig4){ref-type="fig"}). Together, these data demonstrate that B cells play a significant role in directing the expansion of CD4^+^ T cells responding to *Plasmodium* infection independently of DCs. These data also support more recent work demonstrating that antigen presentation by B cells alone is sufficient to drive the expansion and formation of prominent Tfh populations in the context of infection ([@bib34]).

Since B cells can influence the differentiation of CD4^+^ T cells through both antigen presentation and costimulation, we also interrogated how costimulatory signals influence the differentiation of the Tfh response to *Plasmodium* infection. B cells can provide an array of costimulatory signals, including CD40 and ICOSL, which are critical for driving the differentiation of Tfh cells ([@bib6]; [@bib9]; [@bib15]; [@bib23]; [@bib31]; [@bib38]; [@bib56]; [@bib57]; [@bib65]; [@bib66]; [@bib70]; [@bib83]). We therefore began by testing how CD40--CD40L and ICOS--ICOSL interactions direct the differentiation of GP66^+^ cells. We infected WT and MB1-Cre^+^ MHC II^fl/fl^ mice with *Py-GP66,* treated with anti-CD40L and anti-ICOSL antibodies daily for the first 3 d of infection, and analyzed the responses at 4 d after infection. Blocking interactions between these receptor-ligand pairs in WT mice resulted in a 12% decrease in CXCR5^+^ Tfh cells, as well as a 1.7-fold decrease in cell numbers (Fig. S3, B and C). When this treatment was conducted in MB1-Cre^+^ MHC II^fl/fl^ mice to determine if synergy might occur between antigen-dependent and -independent interactions, we observed a nearly 60% decrease in the frequency of CXCR5^+^ T cells, in addition to a 14-fold decrease in the total numbers of GP66^+^ cells (mean = 35.2 cells) compared with isotype-treated controls ([Fig. 4, G and H](#fig4){ref-type="fig"}). Independently, the effects of removing antigen presentation by B cells or blocking costimulation had notable effects on the differentiation of Tfh cells. However, the dramatic reductions in both Tfh cell differentiation and antigen-specific cell expansion when both antigen presentation and costimulatory interactions between CD4^+^ T cells and B cells were blocked highlights the synergy of the multiple cues that determine CD4^+^ T cell fate. These data emphasize the importance of both costimulation and antigen presentation for CD4^+^ T cell fate during the priming phase of the immune response to *Plasmodium* infection.

Conclusion {#s7}
----------

Our data support a model in which B cells serve as the primary APC during blood-stage *Plasmodium* infection. The distinctive role for B cells in this context is likely influenced by diminished DC function ([@bib24]; [@bib44]; [@bib64]; [@bib79]; [@bib87]; [@bib90]) and/or the splenic disruption associated with this infection ([@bib5]). The *Plasmodium*-specific CD4^+^ T cell population acquires a stable CXCR5^+^ Tfh phenotype at acute time points during infection that is maintained late into the memory response. As shown in previous bacterial and viral infections, this early Tfh cell population can form a prominent T~CM~ population ([@bib16]; [@bib20]; [@bib62]). This is in contrast to other studies ([@bib74]; [@bib59]) in which adoptively transferred, *Plasmodium*-specific monoclonal TCR transgenic CD4^+^ T cells predominantly formed an effector memory T (T~EM~) cell population. This result may be due to the specificity of the population that was used, as monoclonal TCR transgenic populations do not always represent the heterogeneity seen in polyclonal endogenous antigen-specific populations ([@bib77]).

This work demonstrates that B cells can provide both peptide:MHC complexes and costimulatory signals required for priming CD4^+^ T cells generated during *Plasmodium* infection. Of interest, several studies have noted an increase in the circulating cDC1 population in humans following *Plasmodium* infection, coupled with a significant decrease in the surface expression of the human MHC II molecule HLA-DR ([@bib3]; [@bib26]; [@bib81]). Many have reported a decrease in antigen uptake and presentation by DCs in both mouse and human studies ([@bib24]; [@bib44]; [@bib64]; [@bib79]; [@bib87]; [@bib90]). Others described a specific dysfunction of the cDCs to prime CD4^+^ T cells due to the type I IFN signaling induced early in infection ([@bib29]). These findings together with our work support the hypothesis that while T cell--promoting cDCs are increased in number, they are significantly hampered in their functionality. This may result in the B cell population being the professional APC population poised to prime CD4^+^ T cells and promote Tfh formation.

Additionally, the architectural changes that have been described in the spleen during *Plasmodium* infection of both mice and humans are characterized by the presence of B cells outside the follicle and a blurring of the red and white pulp areas ([@bib1]; [@bib2]; [@bib5]; [@bib80]). We hypothesize that the loss of well-defined B and T cell areas allows CD4^+^ T and B cells to freely associate and exchange signals that would normally be provided only at the T--B border, resulting in depressed cell numbers and skewed Tfh cell differentiation early in the response to *Plasmodium* infection. While it is unclear whether the costimulatory signals required to form Tfh cells are provided by B cells, it is clear that cDCs are not critical for this function. Overall, the work here demonstrates that B cells play an important role early in the development of the CD4^+^ T cell response during *Plasmodium* infection before antibody production, through antigen presentation and likely costimulatory factors such as CD40 and ICOSL. Elucidating the comprehensive effects of early B cell interactions on acute CD4^+^ T cell responses and their effects on memory CD4^+^ T cell fate in the context of *Plasmodium* infection will provide the field with additional therapeutic targets to improve immunity to *Plasmodium* infection.

Materials and methods {#s8}
=====================

Mice {#s9}
----

4--10-wk-old male C57BL/6, B6.129S2-Ighmtm1Cgn/J (μMT), B6.C(Cg)-Cd79a^tm1(cre)Reth^/EhobJ (MB1-Cre), and B6.129X1-H2-Ab1^tm1Koni^/J (I-A^b\ fl/fl^) mice were purchased from the Jackson Laboratory. MB1-Cre and I-A^b\ fl/fl^ mice were crossed to generate the MB1-Cre^+^ MHC II^fl/fl^ strain. MB1-Cre^−^ MHC II^fl/fl^ littermates were used as controls for these experiments. B6;D2-TCR LCMV RAG-deficient (SMARTA) mice were provided by Dr. James Moon (Massachusetts General Hospital, Harvard Medical School, Boston, MA). CD19-Aβb (B-MHC II) mice ([@bib4]) were provided by Dr. Terri Laufer (University of Pennsylvania, Philadelphia, PA). B6(Cg)-Zbtb46^tm1(HBEGF)Mnz^/J (zDC-DTR) mice ([@bib51]) were provided by Dr. Michael Gerner (University of Washington, Seattle, WA). All animals were bred and housed under specific pathogen--free conditions at the University of Washington. Animals infected with LCMV were housed in Animal Biosafety Level-2 conditions. Experiments were performed in accordance with the University of Washington Institutional Animal Care and Use Committee guidelines.

Parasite and viral infections {#s10}
-----------------------------

*P. yoelii 17XNL-GP66* (*Py-GP66*) parasites ([@bib27]; [@bib91]) were maintained as frozen blood stocks and passaged through donor mice. *Py-GP66* infections were initiated by an i.p. injection of 10^6^ infected RBCs per mouse obtained from donor mice. Parasitemia was determined by flow cytometry based on the percentage of CD45^−^ Ter119^+^ Hoescht^+^ cells ([@bib47]). LCMV-Armstrong strain was provided by Dr. David Masopust (University of Minnesota, Minneapolis, MN). LCMV infections were initiated by i.p. injection of 10^5^ PFU per mouse.

Purified antibody and diphtheria toxin treatments {#s11}
-------------------------------------------------

For depletion of CD20^+^ B cells, mice were anesthetized with isoflurane and treated with anti-CD20 antibody (clone 18B12; generously provided by Biogen Idec) at 10 mg/kg in PBS via i.v. injection. Control mice were treated with 10 mg/kg of isotype control antibody (clone 2B8; Biogen Idec) in PBS via i.v. injection. Doses were administered at 0 and 3 d after infection, according to the depletion kinetics ([@bib18]). For the blockade of CD40-CD40L and ICOS-ICOSL signaling, mice were treated with 0.5 mg of anti-CD40L antibody (clone MR-1; Bio X Cell) and 0.25 mg of anti-ICOSL antibody (clone HK5.3; Bio X Cell) in PBS via i.v. injection daily from 0 to 3 d after infection. Control mice received 0.5 mg and/or 0.25 mg of polyclonal Armenian hamster IgG and rat IgG2, respectively (Bio X Cell). Diphtheria toxin (Sigma) was administered via i.p. injection at 20 ng/g at 1 d before infection and 2 d after infection.

SMARTA cell transfer {#s12}
--------------------

CD4^+^ T cells were isolated from SMARTA mice by negative selection with the CD4^+^ T cell MACS isolation kit (Miltenyi Biotec) and were labeled with CFSE (Invitrogen). Recipient mice were anesthetized with isoflurane and received 10^5^ CFSE-labeled CD4^+^ T cells via i.v. injection 1 d before infection.

Cell enrichment and flow cytometry {#s13}
----------------------------------

Single-cell suspensions were prepared from the spleen and lymph nodes (axial, brachial, cervical, inguinal, mesenteric, and periaortic) from experimental mice in PBS containing 2% heat-inactivated FBS. Cells were stained with GP~66--77~:I-A^b^-APC tetramer (I-A^b^/LCMV.GP66.DIYKGVYQFKSV; National Institutes of Health Tetramer Core) for 1 h at room temperature, washed, and incubated with magnetic anti-APC beads (Miltenyi Biotec) for 30 min on ice. Tetramer-specific cells were enriched as previously described ([@bib52]) using LS MACS columns (Miltenyi Biotec). The enriched cells were stained with antibodies to the following surface markers: CCR7 (clone: 4B12; Biolegend or eBioscience), CD3 (clone: 145-2C11; BD), CD4 (clone: RM4-4, RM4-5, or GK1.5), CD8a (clone: 53--6.7; BD), CD11b (clone: M1/70; eBioscience or BD), CD11c (clone: N418; eBioscience; clone: HL3; BD), CD25 (clone: PC61; BD), CD44 (clone: IM7; BD), CD45R (B220) (clone: RA3-6B2; eBioscience or BD), CD62L (clone: MEL-14; BD), CD69 (clone: H1.2F3; eBioscience), CXCR5 (clone: 2G8; BD), F4/80 (clone: BM8; eBioscience), PD-1 (clone: J43; eBioscience), and streptavidin (BD). For intranuclear transcription factor staining, cells were then fixed with eBioscience Foxp3/Transcription Factor Staining Buffer Set (Thermo Fisher) and stained with antibodies to the following intranuclear molecules: BCL6 (clone: K112-91; BD) and T-bet (clone: eBio4B10; eBioscience). All samples were acquired on the LSR II cytometer (BD) and analyzed using FlowJo software (Tree Star, v9). All flow plots were gated on lymphocyte gate, singlets, B220^−^ CD11b^−^ CD11c^−^ (dump^−^) CD3^+^ CD8^−^ CD4^+^. Additional gating strategies are indicated in the figure legends.

Statistical analysis {#s14}
--------------------

Responder frequency and proliferative capacity were calculated as previously described ([@bib25]). Results represent means ± SEM. Statistical analyses were performed by nonlinear regression, unpaired *t* test, or two-way ANOVA, as specified in figure legends. Statistical tests were calculated using GraphPad Prism (v7).

Online supplemental material {#s15}
----------------------------

Fig. S1 shows the expression of Tfh and T~CM~ markers in naive cells. Fig. S2 shows the impact of B cell loss on parasite burden and the depletion of B cells by anti-CD20 antibody treatment. Fig. S3 shows the depletion of cDCs and the loss of Tfh cells in WT mice in response to CD40L and ICOSL blockade.

*Py-GP66* mosquito passage was generously performed by Alexis Kaushansky (Seattle Children's Research Institute, Seattle, WA). Terri Laufer provided valuable discussions and generously provided mice.
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